China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine

ConditionAmyotrophic Lateral Sclerosis

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorDongzhimen Hospital, Beijing

About this trial

A multi-center registration study of clinical characteristics of amyotrophic lateral sclerosis (ALS) patients with traditional Chinese medicine (TCM).

Eligibility criteria

Qualifiers

Patients aged 18 years and older.

Patients with possible, laboratory supported probable, probable, or definite ALS according to the revised El Escorial criteria.

ALS patients treated with traditional Chinese medicine.

Disqualifiers

Patients who refuse informed consent.

Trial design

Treatments tested in this trial

Not listed

Trial groups

2,000 Participants

are grouped into 1 trial group

Sponsors and collaborators

Dongzhimen Hospital, Beijing

Lead sponsor

Source ClinicalTrials.gov